본문 바로가기
KERD
논문KCI 등재

The Association Between Smoking Tobacco After a Diagnosis of Diabetes and the Prevalence of Diabetic Nephropathy in the Korean Male Population

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Objectives: Smoking is known to be associated with nephropathy in patients with diabetes. The distinct effects of smoking before and after diabetes has been diagnosed, however, are not well characterized. We evaluated the association of cigarette smoking before and after a diagnosis of diabetes with the presence of diabetic nephropathy. Methods: We analyzed data from the 2011-2013 editions of the Korea National Health and Nutrition Examination Survey. A total of 629 male patients diagnosed with diabetes were classified as non-smokers (90 patients), former smokers (225 patients), or continuing smokers (314 patients). A “former smoker” was a patient who smoked only before receiving his diagnosis of diabetes. A “continuing smoker” was a patient who smoked at any time after his diabetes had been diagnosed. Diabetic nephropathy was defined as the presence of albuminuria (spot urine albumin/creatinine ratio ≥30 mg/g) or low estimated glomerular filtration rate (<60 mL/min/1.73 m2). Multiple logistic regression models were used to assess the independent association after adjusting for age, duration of diabetes, hemoglobin A1c, body mass index, systolic blood pressure, medication for hypertension, and medication for dyslipidemia. Female patients were excluded from the study due to the small proportion of females in the survey who smoked. Results: Compared to non-smokers, continuing smokers had significantly higher odds ratio ([OR], 2.17; 95% confidence interval [CI], 1.23 to 3.83) of suffering from diabetic nephropathy. The corresponding OR (95% CI) for former smokers was 1.26 (0.70 to 2.29). Conclusions: Smoking after diagnosis of diabetes is significantly associated with the presence of diabetic nephropathy in the Korean male population.

Abstract

Objectives: Smoking is known to be associated with nephropathy in patients with diabetes. The distinct effects of smoking before and after diabetes has been diagnosed, however, are not well characterized. We evaluated the association of cigarette smoking before and after a diagnosis of diabetes with the presence of diabetic nephropathy. Methods: We analyzed data from the 2011-2013 editions of the Korea National Health and Nutrition Examination Survey. A total of 629 male patients diagnosed with diabetes were classified as non-smokers (90 patients), former smokers (225 patients), or continuing smokers (314 patients). A “former smoker” was a patient who smoked only before receiving his diagnosis of diabetes. A “continuing smoker” was a patient who smoked at any time after his diabetes had been diagnosed. Diabetic nephropathy was defined as the presence of albuminuria (spot urine albumin/creatinine ratio ≥30 mg/g) or low estimated glomerular filtration rate (<60 mL/min/1.73 m2). Multiple logistic regression models were used to assess the independent association after adjusting for age, duration of diabetes, hemoglobin A1c, body mass index, systolic blood pressure, medication for hypertension, and medication for dyslipidemia. Female patients were excluded from the study due to the small proportion of females in the survey who smoked. Results: Compared to non-smokers, continuing smokers had significantly higher odds ratio ([OR], 2.17; 95% confidence interval [CI], 1.23 to 3.83) of suffering from diabetic nephropathy. The corresponding OR (95% CI) for former smokers was 1.26 (0.70 to 2.29). Conclusions: Smoking after diagnosis of diabetes is significantly associated with the presence of diabetic nephropathy in the Korean male population.

참고문헌 (37)

  1. 안재희, "Prevalence and Determinants of Diabetic Nephropathy in Korea: Korea National Health and Nutrition Examination Survey", Diabetes and Metabolism Journal, 38(2), pp.109~119 (2014), 대한당뇨병학회[DOI]
  2. de Boer IH, "Cystatin C, albuminuria, and mortality among older adults with diabetes", Diabetes Care, 32(10), pp.1833~1838 (2009)
  3. Gerstein HC, "Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals", JAMA, 286(4), pp.421~426 (2001)
  4. Molitch ME, "Nephropathy in diabetes", Diabetes Care, 27(Suppl 1), pp.S79~S83 (2004)
  5. 진동찬, "Major changes and improvements of dialysis therapy in Korea: review of end-stage renal disease registry", The Korean Journal of Internal Medicine, 30(1), pp.17~22 (2015), 대한내과학회[DOI]
  6. 김태호, "Direct Medical Costs for Patients with Type 2 Diabetes and Related Complications: A Prospective Cohort Study Based on the Korean National Diabetes Program", Journal of Korean Medical Science, 27(8), pp.876~882 (2012), 대한의학회[DOI]
  7. Raptis AE, "Pathogenesis of diabetic nephropathy", Exp Clin Endocrinol Diabetes, 109(Suppl 2), pp.S424~S437 (2001)
  8. Chuahirun T, "Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes", Am J Kidney Dis, 41(1), pp.13~21 (2003)
  9. Maija Feodoroff, "Smoking and progression of diabetic nephropathy in patients with type 1 diabetes", Acta Diabetologica, 53(4), pp.525~533 (2016), Springer Nature[DOI]
  10. Sawicki PT, "Smoking is associated with progression of diabetic nephropathy", Diabetes Care, 17(2), pp.126~131 (1994)
  11. Gregg EW, "Changes in diabetes-related complications in the United States, 1990-2010", N Engl J Med, 370(16), pp.1514~1523 (2014)
  12. Chuahirun T, "Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes", Am J Med Sci, 327(2), pp.57~67 (2004)
  13. Phisitkul K, "Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy", Am J Med Sci, 335(4), pp.284~291 (2008)
  14. Pinto-Sietsma SJ, "Smoking is related to albuminuria and abnormal renal function in nondiabetic persons", Ann Intern Med, 133(8), pp.585~591 (2000)
  15. Gupta RK, "Impact of smoking on microalbuminuria and urinary albumin creatinine ratio in non-diabetic normotensive smokers", Indian J Nephrol, 24(2), pp.92~96 (2014)
  16. Kweon S, "Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES)", Int J Epidemiol, 43(1), pp.69~77 (2014)
  17. Jung-Choi KH, "Hidden female smokers in Asia: a comparison of self-reported with cotinine-verified smoking prevalence rates in representative national data from an Asian population", Tob Control, 21(6), pp.536~542 (2012)
  18. Levey AS, "The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report", Kidney Int, 80(1), pp.17~28 (2011)
  19. Baggio B, "Effects of cigarette smoking on glomerular structure and function in type 2 diabetic patients", J Am Soc Nephrol, 13(11), pp.2730~2736 (2002)
  20. Cirillo M, "Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: the Gubbio Population Study", Arch Intern Med, 158(17), pp.1933~1939 (1998)
  21. Tozawa M, "Influence of smoking and obesity on the development of proteinuria", Kidney Int, 62(3), pp.956~962 (2002)
  22. Voulgari C, "Smoking cessation predicts amelioration of microalbuminuria in newly diagnosed type 2 diabetes mellitus: a 1-year prospective study", Metabolism, 60(10), pp.1456~1464 (2011)
  23. Hallan SI, "Smoking is a risk factor in the progression to kidney failure", Kidney Int, 80(5), pp.516~523 (2011)
  24. Luo J, "Smoking and diabetes: does the increased risk ever go away", Am J Epidemiol, 178(6), pp.937~945 (2013)
  25. Chakkarwar VA, "Smoking in diabetic nephropathy: sparks in the fuel tank", World J Diabetes, 3(12), pp.186~195 (2012)
  26. Giacco F, "Oxidative stress and diabetic complications", Circ Res, 107(9), pp.1058~1070 (2010)
  27. Craig WY, "Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data", BMJ, 298(6676), pp.784~788 (1989)
  28. Freeman DJ, "The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma", Eur J Clin Invest, 28(7), pp.584~591 (1998)
  29. Esmatjes E, "Smoking increases serum levels of transforming growth factor-beta in diabetic patients", Diabetes Care, 22(11), pp.1915~1916 (1999)
  30. Gulliford MC, "Low rates of detection and treatment of hypertension among current cigarette smokers", J Hum Hypertens, 15(11), pp.771~773 (2001)
  31. John U, "Relation between awareness of circulatory disorders and smoking in a general population health examination", BMC Public Health, 6, pp.48~ (2006)
  32. Muggeo M, "Accelerated complications in type 2 diabetes mellitus: the need for greater awareness and earlier detection", Diabet Med, 15(Suppl 4), pp.S60~S62 (1998)
  33. Ekberg G, "Cigarette smoking and glomerular filtration rate in insulin-treated diabetics without manifest nephropathy", J Intern Med, 228(3), pp.211~217 (1990)
  34. Orth SR, "Effects of smoking on systemic and intrarenal hemodynamics: influence on renal function", J Am Soc Nephrol, 15(Suppl 1), pp.S58~S63 (2004)
  35. 김양호, "Inappropriate Survey Design Analysis of the Korean National Health and Nutrition Examination Survey May Produce Biased Results", 예방의학회지, 46(2), pp.96~104 (2013), 대한예방의학회
  36. American Diabetes Association, "Executive summary: standards of medical care in diabetes--2011", Diabetes Care, 34(Suppl 1), pp.S4~S10 (2011)
  37. Chuang LM, "Diabcare-Asia 1998Study Group. The status of diabetes control in Asia--a crosssectional survey of 24 317 patients with diabetes mellitus in 1998", Diabet Med, 19(12), pp.978~985 (2002)

이 간행물의 다른 논문 (8건)